Sugammadex 100 Mg/1 Ml Fresenius, Sugammadex 200 Mg/2 Ml Fresenius, Sugammadex 500 Mg/5 Ml Fresenius 100 mg/1 mL , 200 mg/2 mL, 500 mg/5 mL Solution for injection.
Clinical Summary
Quick overview from the medicine insert
Indication
Routine and immediate reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Dosage (summary)
4 mg/kg for profound blockade, 2 mg/kg for shallow blockade, 16 mg/kg for immediate reversal at 3 mins.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
- Obese patients
- Paediatric patients
Pregnancy & Breastfeeding
Caution in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- Toremifene
- Fusidic acid
- Hormonal contraceptives
Contraindications
- Hypersensitivity to sugammadex or excipients
Common side effects
- Cough
- Dysgeusia
- Headache
- Marked bradycardia
Counselling Points
- Monitor for signs of recurrence of neuromuscular blockade.
- Ventilatory support may be required post-administration.
- Inform about potential hypersensitivity reactions.
Serious warnings
- Not for use with depolarising neuromuscular blockers
- Risk of recurrence of neuromuscular blockade
- Marked bradycardia observed
The Sugammadex 100 Mg/1 Ml Fresenius, Sugammadex 200 Mg/2 Ml Fresenius, Sugammadex 500 Mg/5 Ml Fresenius 100 mg/1 mL , 200 mg/2 mL, 500 mg/5 mL Solution for injection. professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.